These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2039813)

  • 21. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved designs for dose escalation studies using pharmacokinetic measurements.
    Piantadosi S; Liu G
    Stat Med; 1996 Aug; 15(15):1605-18. PubMed ID: 8858785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of saturable distribution in compartmental PK models: dynamics and practical use.
    Peletier LA; de Winter W
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):1-16. PubMed ID: 28050672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB; Robinson BA
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):305-25. PubMed ID: 3668806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Area-based estimation of the initial volume of distribution and elimination rate constant following intravenous bolus injection.
    Khor SP; Johnson SL; Mayersohn M
    J Pharm Sci; 1991 Nov; 80(11):1042-50. PubMed ID: 1815055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of trimethoprim in the rat.
    Tu YH; Allen LV; Fiorica VM; Albers DD
    J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching from body surface area-based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis.
    Gupta N; Zhao Y; Hui AM; Esseltine DL; Venkatakrishnan K
    Br J Clin Pharmacol; 2015 May; 79(5):789-800. PubMed ID: 25377318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
    Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.
    Korzekwa K; Nagar S
    Drug Metab Dispos; 2023 Apr; 51(4):532-542. PubMed ID: 36623886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect.
    Tubic M; Wagner D; Spahn-Langguth H; Bolger MB; Langguth P
    Pharm Res; 2006 Aug; 23(8):1712-20. PubMed ID: 16832615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.
    Mehvar R
    Pharm Res; 1991 Mar; 8(3):306-12. PubMed ID: 2052516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded version of PKSIM for pharmacokinetic simulations of both metabolite and parent drugs.
    Li RC; Wong SL; Chan KK
    Am J Ther; 1997 Jan; 4(1):16-22. PubMed ID: 10423585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of morphine-6-glucuronide and its formation from morphine after intravenous administration.
    Lötsch J; Weiss M; Kobal G; Geisslinger G
    Clin Pharmacol Ther; 1998 Jun; 63(6):629-39. PubMed ID: 9663177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent.
    Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.